InfiniGene

InfiniGene is a private Palo Alto-based diagnostics company founded in 2014. Publicly available company-profile sources describe it as a provider of diagnostic products and services and indicate that it has operated in stealth mode. The company appears to have been associated with the StartX ecosystem, with StartX listed as an investor and contemporaneous reporting identifying founder Michael Niaki as leading a diagnostics startup under the InfiniGene name. Very limited public information is available on specific products, pipeline assets, targets, or clinical-stage programs, suggesting the business has remained early-stage and relatively undisclosed. Based on available evidence, InfiniGene is best characterized as a private diagnostics/healthcare startup rather than a therapeutics developer.